Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.
Year: 2001
Type: article
Source: PubMed
Institution: Pfizer (United States)
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1889354068